A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. [electronic resource]
Producer: 20050630Description: 5-19 p. digitalISSN:- 0586-7614
- Antipsychotic Agents
- Brief Psychiatric Rating Scale
- Clinical Trials as Topic -- standards
- Cognition Disorders -- diagnosis
- Combined Modality Therapy
- Guidelines as Topic
- Health Promotion
- Humans
- Mental Health Services -- standards
- National Institute of Mental Health (U.S.)
- Polypharmacy
- Psychotherapy
- Schizophrenia -- complications
- Severity of Illness Index
- Treatment Outcome
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Congress; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.